SAN DIEGO–(BUSINESS WIRE)– #ArtisBioSolutions–Artis BioSolutions, an advanced therapies company built to streamline the discovery, development, and production of genetic medicines, today announced that both Landmark Bio, its Watertown, Massachusetts-based development and GMP manufacturing operation, and Syngoi, its Bilbao, Spain-based enzymatic synthetic DNA business, will now operate under the Artis BioSolutions name. The change unifies Artis’ U.S. and European capabilities under a single brand, completing a tr
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
